Sponsor Dossier
Eugia Pharma
Sponsor Dossier for Eugia Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AZACITIDINE
- Brand: BENDAMUSTINE
- Brand: BORTEZOMIB
- Brand: CARBOPLATIN
- Brand: EUG-AZACITIDINE
- Brand: EUG-BENDAMUSTINE
- Brand: EUG-BORTEZOMIB
- Brand: EUG-CARBOPLATIN
About
Eugia Pharma is an Australian Private Company with ABN 57656083028, registered in Victoria. The company is currently active and GST-registered.
Portfolio
Eugia Pharma has 19 brands on the ARTG, of which 9 are indexable and 9 carry a Product Information document. 6 brands are PBS-listed, 1 has a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include AZACITIDINE, BENDAMUSTINE, BORTEZOMIB, CARBOPLATIN, EUG-AZACITIDINE, EUG-BENDAMUSTINE, EUG-BORTEZOMIB, EUG-CARBOPLATIN, EUG-FLUCLOXACILLIN, EUG-FULVESTRANT, EUG-IRINOTECAN, EUG-PEMETREXED.
Therapeutic focus
— Oncology: 15 brands — Infectious Disease: 2 brands — Haematology: 2 brands
PBS footprint
6 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2010-03-01, across 1 brand with a PBAC outcome on record.